SEGMENTS (Tables)

9 Months Ended

Sep. 30, 2023

SEGMENTS [Abstract]

Summarized Financial Information Concerning Reportable Segments

Summarized financial information concerning reportable segments is shown in the following tables:

Three Months Ended September 30, 2023
	ADMA BioManufacturing			Plasma Collection Centers			Corporate			Consolidated
Revenues	$	66,566,884		$	672,006		$	35,708		$	67,274,598
Cost of product revenue		41,733,958			888,055			-			42,622,013
Income (loss) from operations		15,016,875			(682,947	)		(5,648,769	)		8,685,159
Interest and other expense, net		(140,669	)		(400	)		(5,979,035	)		(6,120,104	)
Net income (loss)		14,876,206			(683,347	)		(11,627,804	)		2,565,055
Total assets		262,553,540			35,621,536			50,821,489			348,996,565
Depreciation and amortization expense		1,282,076			810,432			-			2,092,508

Three Months Ended September 30, 2022
	ADMA			Plasma Collection
	BioManufacturing			Centers			Corporate			Consolidated
Revenues	$	37,280,798		$	3,773,631		$	35,708		$	41,090,137
Cost of product revenue		27,883,046			3,550,450			-			31,433,496
Income (loss) from operations		297,310			(4,636,269	)		(4,977,774	)		(9,316,733	)
Interest and other expense, net		(3,023	)		(154	)		(5,579,594	)		(5,582,771	)
Net income (loss)		294,287			(4,636,423	)		(10,557,368	)		(14,899,504	)
Total assets		242,983,498			39,125,933			18,448,139			300,557,570
Depreciation and amortization expense		1,214,529			647,463			-			1,861,992

Nine Months Ended September 30, 2023
	ADMA			Plasma Collection
	BioManufacturing			Centers			Corporate			Consolidated
Revenues	$	175,904,955		$	8,299,243		$	107,125		$	184,311,323
Cost of product revenue		118,708,495			7,747,250			-			126,455,745
Income (loss) from operations		26,576,977			(3,028,792	)		(16,149,421	)		7,398,764
Interest and other expense, net		(170,069	)		(605	)		(17,822,557	)		(17,993,231	)
Net income (loss)		26,406,908			(3,029,397	)		(33,971,978	)		(10,594,467	)
Capital expenditures		1,767,825			1,805,961			-			3,573,786
Depreciation and amortization expense		3,857,085			2,365,965			-			6,223,050

Nine Months Ended September 30, 2022
	ADMA			Plasma Collection
	BioManufacturing			Centers			Corporate			Consolidated
Revenues	$	95,129,542		$	8,861,570		$	107,125		$	104,098,237
Cost of product revenue		74,383,948			8,626,208			-			83,010,156
Loss from operations		(4,423,228	)		(12,520,163	)		(16,363,147	)		(33,306,538	)
Interest and other expense, net		(70,084	)		(1,221	)		(13,624,483	)		(13,695,788	)
Loss on extinguishment of debt		-			-			(6,669,941	)		(6,669,941	)
Net loss		(4,493,312	)		(12,521,384	)		(36,657,571	)		(53,672,267	)
Capital expenditures		4,292,246			5,870,404			-			10,162,650
Depreciation and amortization expense		3,486,212			1,689,362			918			5,176,492

Net Revenues According to Geographic Area

Net revenues according to geographic area, based on the location of where the product is shipped, is as follows:

	Three Months Ended September 30,				Nine Months Ended September 30,
	2023		2022		2023		2022
United States	$	64,617,747	$	37,854,167	$	173,920,284	$	96,445,162
International		2,656,851		3,235,970		10,391,039		7,653,075
Total revenues	$	67,274,598	$	41,090,137	$	184,311,323	$	104,098,237